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Abstract
Background: Human rhinoviruses (RV), the most common triggers of acute asthma exacerbations,
are considered not cytotoxic to the bronchial epithelium. Recent observations, however, have
questioned this knowledge. The aim of this study was to evaluate the ability of RV to induce
epithelial cytotoxicity and affect epithelial repair in-vitro.
Methods: Monolayers of BEAS-2B bronchial epithelial cells, seeded at different densities were
exposed to RV serotypes 1b, 5, 7, 9, 14, 16. Cytotoxicity was assessed chromatometrically.
Epithelial monolayers were mechanically wounded, exposed or not to RV and the repopulation of
the damaged area was assessed by image analysis. Finally epithelial cell proliferation was assessed
by quantitation of proliferating cell nuclear antigen (PCNA) by flow cytometry.
Results: RV1b, RV5, RV7, RV14 and RV16 were able to induce considerable epithelial cytotoxicity,
more pronounced in less dense cultures, in a cell-density and dose-dependent manner. RV9 was
not cytotoxic. Furthermore, RV infection diminished the self-repair capacity of bronchial epithelial
cells and reduced cell proliferation.
Conclusion: RV-induced epithelial cytotoxicity may become considerable in already compromised
epithelium, such as in the case of asthma. The RV-induced impairment on epithelial proliferation
and self-repair capacity may contribute to the development of airway remodeling.
Background
The bronchial epithelium plays a unique role as a protec-
tive physical and functional barrier between external envi-
ronment and underlying tissues. As a result of this role it
is frequently injured and epithelial integrity is damaged. A
repair process starts quickly which includes migration of
the remaining basal airway epithelial cells to repopulate
damaged areas, and subsequent proliferation and differ-
entiation until epithelial integrity has been restored [1,2].
Epithelial damage is a key feature of asthma. As a result of
inflammation, a large portion of columnar epithelial cells
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shed and form Creola bodies, detected in sputum and
during bronchoscopy in asthmatic patients [3]. This cycle
of damage and repair has been proposed as a key mecha-
nism leading to thickening of the airway wall, and other
pathologic alterations collectively characterized as airway
remodeling [4], which in turn has been associated with
incompletely reversible airway narrowing, bronchial
hyper-responsiveness and asthma symptoms [5].
Many factors can be cytotoxic to the bronchial epithelium,
including eosinophil products [6], allergens [7] and respi-
ratory viruses. Virus-induced cytotoxicity has been well
documented for the majority of these agents, including
influenza, parainfluenza, adenovirus and respiratory syn-
cytial virus (RSV) [8]. In contrast, human rhinoviruses
(RVs), although the most preponderant viruses associated
with acute asthma exacerbations [9], have been shown to
induce minimal, if any, cytotoxicity [10-12]. We have
recently shown that RVs are able to replicate in human
primary bronchial epithelial cells [13]. An unexpected
finding in that study was that exposure of sparely seeded
cell monolayers resulted in a considerable RV-specific
cytopathic effect (CPE). RV-induced CPE was also
reported in another study, in which case it was attributed
to specific RV serotypes [14].
Based on the above, we hypothesized that RV infection
may be conditionally able to affect epithelial cell viability
and life-death cycle. Therefore, in this study we used
BEAS-2B cells, a well-established in-vitro lower respiratory
epithelium model of RV infection [15,16], used in parallel
studies with primary bronchial epithelial cells [17,18]as
well in cell death studies [19]to systematically investigate
the ability of RV to induce cytotoxicity in bronchial epi-
thelial cells. Furthermore, the effect of RV on an in-vitro
model of epithelial wound repair was assessed.
Methods
Cell cultures
BEAS-2B cells, a human continuous bronchial epithelial
cell line and Ohio-HeLa cells (obtained from ATCC and
the MRC Cold Unit, UK, respectively) were cultured in
Eagle's minimal essential medium (E-MEM) buffered
with NaHCO3 and supplemented with 10% (v/v) fetal
bovine serum (FBS) and 40 µg/ml of gentamycin, in a
humified 5% CO2  incubator. Cells were spilt twice
weekly.
Primary human bronchial epithelial cells (HBECs), ini-
tially deriving from an adult non-asthmatic volunteer in
the course of another ongoing study, were available fro-
zen in liquid nitrogen. They were isolated as described
earlier [13]. Cells were rapidly thawed and cultured on
plates pre-coated with collagen type-I (Nutacon, Hol-
land), submerged in Clonetics BEGM (Cambrex, ML,
USA). Medium was replaced daily. Cells were used at pas-
sage 2, at a confluence of 50%. It should be pointed out
that cells in these submerged cultures are undifferentiated
and do not form tight junctions [20].
All culture reagents were purchased from Gibco-Invitro-
gen Corp. (Carlsbad, CA, USA) and Falcon (Becton Dick-
inson, Labware, NJ, USA) and biochemicals were from
Sigma (St. Louis, MO, USA), unless otherwise specified.
Virus cultures and titration
Rhinovirus types 5, 7, 9, 14 and 16 (major subtypes) and
1b (minor subtype) were propagated in Ohio-HeLa cells
in large quantities at 33°C, in a humified, 5% CO2 incu-
bator, as previously described[16]. Briefly, when full cyto-
pathic effect (CPE) developed, cells and supernatants were
harvested, pooled, frozen and thawed twice, clarified, ster-
ile-filtered, aliquoted and stored at -70°C. Lysates of par-
allel Ohio-HeLa cell cultures, not infected with virus, were
used as controls.
In order to determine RV titers, Ohio-HeLa cells were
seeded in 96-well plates reaching 60–70% confluence at
the time of infection. Logarithmic dilutions of RVs were
made in multiple wells and after five days of culture the
plates were fixed and stained with Crystal Violet Buffer
(5% formaldehyde, 5% ethanol and 0.1% crystal Violet in
PBS). The end-point titer was defined as the highest dilu-
tion at which a CPE was detected in at least half of the
wells and expressed as the inverse logarithm of this dilu-
tion (MOI-multiplicity of infection-infectious units/cell).
For each experiment, a new vial was rapidly thawed and
used immediately [21].
In order to assess the specificity of RV-mediated
responses, RV preparations were exposed to 58°C for 1 h.
The successful inactivation was confirmed by lack of RV
replication in Ohio-HeLa cells.
Cytotoxicity assay
BEAS-2B cells were plated in 48-well plates in serial dilu-
tions and allowed to grow for 48 hours, reaching conflu-
ence of 100%, 50%, 25% and 12.5%. Cell numbers and
respective confluence were assessed by standard Neubauer
cytometer in initial experiments. Cells were then exposed
to rhinovirus as previously described [16]. Briefly wells
were washed with HBSS and virus was added at the desir-
able MOI in parallel to non-infected Ohio HeLa cell lysate
negative controls. The amount of the virus added was pro-
portional to the number of the cells. After 1 hour of gentle
shaking at room temperature, fresh medium was added,
to a final volume of 0.5 ml. Eagle's MEM supplemented
with 4% FCS, 1% MgCl and 4% tryptose phosphate broth
and 40 µg/ml of gentamycin, was used for the experi-
ments. After 48 hours of incubation, cells were washedRespiratory Research 2005, 6:114 http://respiratory-research.com/content/6/1/114
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Cytotoxicity of different RV serotypes; 1b, 7, 14, 5, 16 and 9, at MOI = 1 on BEAS-2B cells, cultured until reaching different  densities (100, 50, 25 and 12.5%) Figure 1
Cytotoxicity of different RV serotypes; 1b, 7, 14, 5, 16 and 9, at MOI = 1 on BEAS-2B cells, cultured until reaching different 
densities (100, 50, 25 and 12.5%). An inverse correlation between cell density and RV-induced cytotoxicity is observed for 
RV1b, RV7, RV14 and RV16, (*p < 0.05, n = 3–26, linear regression).Respiratory Research 2005, 6:114 http://respiratory-research.com/content/6/1/114
Page 4 of 11
(page number not for citation purposes)
twice in PBS and a volume of crystal violet staining buffer
equal to 1/5th of the original culture medium was added
to the wells as indicator of cell viability [22,23]. Cells were
incubated for 30 min at room temperature followed by
extensive washing with distilled water. After air drying 0.2
ml of a destain buffer (16.6% v/v glacial acetic acid, 50%
v/v methanol in ultra pure water) was added to the wells
for 5 min. Cells were fully destained and the produced
color was transferred to a clear 96 well ELISA plate and
optical density was measured with a photometer at 595
nm (Ceres 900C, Bio-Tec Instruments, Inc, Winooski VT,
USA) [13]. Cytotoxicity was estimated as % of the negative
control (1- O.D RV infected/O.D HeLa * 100).
Epithelial repair assay
Confluent monolayers of BEAS-2B cells were grown in 48-
well plates. Cells were then damaged mechanically by
crossing three times with a 10–200 µL volume universal
pipette tip (Corning, NY, USA) [1]. After washing twice
with HBSS cells were infected with RV1b at MOI 0.5, in
parallel to non-damaged monolayers as well as HeLa
lysate controls as described above and incubated in a
humified 5% CO2 incubator. Immediately after infection
(t = 0) and at 24, 48 and 72 hours a plate was stained with
crystal violet. Wells were photographed and the area of
unpopulated cells was calculated with image analysis,
(Scion Image software, b4.0.2, NIH). Furthermore, cyto-
toxicity was estimated, as described above.
In some experiments, cells were fixed and stained with 4,
6 diamino-2-phenylindole (DAPI), a DNA-binding dye.
They were then viewed using a UV-visible Zeiss Axioplan
2 fluorescent microscope and fluorescence images were
captured using a CCD camera.
Proliferation Assay
BEAS-2B cells were cultured in 25 cm2 flasks until conflu-
ent. After infection with RV 1b at 0.5 MOI or control, cells
were incubated for an additional 24 hours at 33°C. They
were then washed twice with HBSS, detached using a non-
enzymatic cell dissociation buffer (Gibco, UK), split 1:2 in
new flasks and re-incubated. At that time, as well as at 24,
48 and 72 hours later proliferation was estimated by stain-
ing with Proliferating Cell Nuclear Antigen (PCNA), a
proliferation marker correlates with other markers of the
S phase of cell cycle like tritiated thymidine and Bromode-
oxyuridine labeling [24]. PCNA assessed with flow cytom-
etry [25].
Flow Cytometry
BEAS-2B cells were harvested non-enzymatically and
resuspended at a density of 1 × 105 cells/100 µl in washing
buffer (PBS with 1% FBS). For ICAM-1 analysis cells were
incubated with 20 µL anti-ICAM, phycoerythin-conju-
gated monoclonal antibody (Pharmingen, Becton Dickin-
son, Jan Hose, CA, USA) for 30 min at 4°C. After washing
twice, cells were fixed with 0.5 ml of 1% paraformalde-
hyde in PBS and counted with a FACSort (Becton Dickin-
son, Jan Hose, CA, USA) flow cytometer. Fluorescence
data were collected on 104cells and histogram analysis
was performed with the use of Cell Quest software™.
For PCNA analysis, cells were permeabilized in a buffer
comprising of 0.2 mg/ml Na2HPO4-2H2O, 1 mg/ml
KH2PO4, 45% v/v acetone and 9.25% v/v formaldehyde
[25], followed immediately by staining with 10 µL of an
anti-PCNA, fluorescein-conjugated monoclonal antibody
(Pharmingen, Becton Dickinson, Jan Hose, Ca, USA). Flu-
orescence data from 104 cells were collected and histo-
gram analysis was performed with Cell Quest software.
Cell viability was assessed by staining with 7-aminoactin-
omycin D (7-AAD) (Becton-Dickinson, San Jose, Calif.,
USA).
Statistical Analysis
Data are expressed as mean ± standard error of mean. Sta-
tistical analysis was conducted with the SPSS 11.0 for
Windows software. Linear regression analysis was used to
evaluate the effect of cell density, and ANOVA for time
and dose comparisons. Means were compared by non-
parametric tests. P values less than 5% were considered
significant.
Results
Rhinoviruses induce cytotoxicity in bronchial epithelial 
cells in a serotype and cell density- depended manner
BEAS-2B cultures were infected with RV1b, RV5, RV7,
RV9, RV14 and RV16 at an MOI of 1 and confluences of
12.5%, 25%, 50% and 100%. The extent of RV-induced
cytotoxicity differed between RV serotypes: RV9 was not
cytotoxic at all at this MOI. RV1b and RV7 were the most
cytotoxic, able to induce cytotoxicity even on confluent
monolayers, while killing over 65%–70% of less dense
cultures. RV14 and RV5 were moderately cytotoxic while
RV16 could kill only sparsely seeded cells. Differences in
RV-induced cell death between RV serotypes were statisti-
cally significant at all cell densities (p = 0.00 in all cases,
ANOVA). Furthermore, a statistically significant inverse
correlation between cell density and RV-induced cytotox-
icity was observed for RV1b, RV7, RV14 and RV16, (p =
0.000, 0.000, 0.014 and 0.03 respectively, linear regres-
sion); RV5 was moderately cytotoxic at all cell densities.
Figure 1 shows the % cytotoxicity of each RV serotype at
different cell densities.
HBEC infected with 1 MOI of RV 1b, RV7 and RV16 at
50% confluence (n = 4), showed cytotoxicity levels of 50
± 1%, 52 ± 3% and 0% respectively, almost identical to
those observed in BEAS-2B cells under the same condi-Respiratory Research 2005, 6:114 http://respiratory-research.com/content/6/1/114
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tions, confirming that the described phenomenon is
reproducible in primary cells.
Rhinovirus-induced cytotoxicity is dose depended
Subsequently, dose-dependence of cytotoxicity was
assessed using RV1b, RV5, RV9 and RV16. At MOI-5, RV9
remained non-cytotoxic (data not shown). RV16 (Figure
2A), but even more RV 5 (Figure 2B), became cytotoxic on
a cell-density dependent manner (p = 0.007 and p =
0.000, respectively, linear regression). RV1b at an MOI of
5 was able to kill almost 50% of a confluent monolayer,
reaching a plateau of 85%–89% of cytoxicity in less dense
cultures (Figure 2C). A dose-response was observed when
comparing cytotoxicity of RV1b both in 100% confluent
(16.5% ± 4.45, 34.66% ± 1.85, 49.65% ± 5.24 at 0.5, 1
and 5 MOI respectively, p = 0.000, ANOVA) and 50% con-
fluent monolayers (23.76% ± 9.66, 58.75% ± 3.62,
86.46% ± 0.62 at 0.5, 1 and 5 MOI respectively, p = 0.000,
ANOVA) (Figure 2D).
RV- induced cytotoxicity is specific
To determine whether the observed cytotoxicity is specific
to RV and not associated with factors in the virus prepara-
tion, we exposed a 50% confluent monolayer to 1 MOI of
heat-inactivated RV 1b. Inactivated RV1b lost its capacity
to induce cell death (6.43% ± 3.68 vs. 55.87% ± 2.68 of
live virus, p = 0.021, Mann-Whitney) (Figure 3).
ICAM-1 expression is not affected by cell density
To test whether cell-density dependent, differential sus-
ceptibility of BEAS-2B cells to RV cytotoxicity may relate
to variations of ICAM-1 expression, the major RV recep-
tor, cells were cultured as described above and expression
of ICAM-1 was measured by flow cytometry. In all densi-
Cytotoxicity of RV16 (A), RV5 (B) and RV1b (C) at MOI = 5 on BEAS-2B cells, cultured until reaching different densities (100,  50, 25 and 12.5%, n = 3–8) Figure 2
Cytotoxicity of RV16 (A), RV5 (B) and RV1b (C) at MOI = 5 on BEAS-2B cells, cultured until reaching different densities (100, 
50, 25 and 12.5%, n = 3–8). RVs became more cytotoxic at this MOI, and density dependence appeared for RV5. Dose depend-
ence is shown for RV1b (D) at 0.5, 1, and 5 MOI for both 100% and 50% cell densities (p = 0.000 in both cases, n = 6, 
ANOVA).
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ties cells expressed ICAM-1 over 98.5%, without differ-
ences on fluorescence intensity (1030.6 ± 88.76, 980 ±
48.47, 964.29 ± 25.52 and 987.38 ± 37.5, at cell densities
of 100%, 50%, 25% and 12.5% respectively).
RV infection delays epithelial wound repair
To test whether infection with RV may affect the self-repair
capacity of bronchial epithelial cell monolayers, digital
photos were taken immediately after mechanical damage
(t = 0) as well as 24, 48 and 72 hours later in infected and
non-infected monolayers. The damaged area not popu-
lated with cells was calculated by image analysis. Control
cells demonstrated a fast response in repopulating the
damaged area (from 133.07 ± 14.67 mm2 at t = 0 to 72.92
± 3.59, 28.09 ± 3.11 and 13.49 ± 1.9 at 24, 48 and 72
hours respectively, p = 0.000, ANOVA). The damaged area
in infected monolayers was repopulated considerably
more slowly, while it seemed to plateau at 48 hours (t = 0,
124.41 ± 9.26 mm2, t = 24 h, 89.13 ± 5.55, t = 48 h, 52.18
± 10.5, t = 72 h, 69.5 ± 6.3, p = 0.00, ANOVA). When
infected and non-infected cells were compared, differ-
ences were significant at all time points (p = 0.024, 0.031
and 0.001 at 24, 48 and 72 hours respectively, Mann
Whitney), (Figure 4).
Furthermore, intact and wounded monolayers did not dif-
fer in susceptibility to RV-mediated cytotoxicity (17.13%
± 4.11 versus 17.64% ± 2.6 at 48 hours after infection for
intact and wounded respectively), suggesting that epithe-
lial wounding leaves unaffected the remaining cells of the
monolayer in respect to RV-induced cytotoxicity.
RV infection decreases epithelial cell proliferation
The expression of PCNA, reflecting proliferative activity of
epithelial cells, increased 24 hours after seeding, followed
by a trend towards return to baseline at 48 and 72 h. How-
ever, PCNA expression (Mean Fluorescence Intensity,
MFI) was significantly lower at all time points in RV-
infected cells (Figure 5). Cell viability, assessed by 7ADD
staining, was over 90% in these experiments.
Discussion
In contrast to previous knowledge, but in line with recent
observations, this study demonstrates that human rhino-
viruses, the agents most frequently associated with acute
asthma exacerbations [26], are able to become cytotoxic
in an in-vitro model of human bronchial epithelium. A
continuous cell line model was used for the majority of
experiments; however, the finding was also confirmed in
primary bronchial cells. Furthermore, it is shown for the
first time that RV infection may delay epithelial wound
healing by affecting epithelial cell proliferation.
It has been generally accepted that RVs do not induce
cytotoxicity in-vitro or in-vivo [27-29], even in heavy
colds [10-12,30]. However, two recent studies designed to
assess the ability of RV to infect primary human bronchial
epithelial cells have unexpectedly observed RV-associated
cytotoxicity: in the study of Schroth et al [14], RV16 and
RV49 were used and cytotoxicity was observed only with
the latter serotype; the authors hypothesized that a higher
viral binding and/or larger yield by RV49 may explain
their observation, noting however the need for additional
studies. This was also the case in the study of Papadopou-
los et al. [13] in which RV cytotoxicity was observed when
sparsely seeded cultures were exposed to the virus. The
current study, which systematically addressed these possi-
bilities, demonstrates that they are both reproducible, and
in fact different RV serotypes differ in their cytotoxic
capacity, which in most cases, is nevertheless cell density
dependent. The latter finding can also explain why RV
cytotoxicity was not observed in previous in-vitro studies,
which were conducted with confluent cultures [28,29].
A recent comprehensive study from Deszcz et al [31] is in
support of our findings, as it shows that RV14 can induce
high levels of cytotoxicity in a bronchial epithelial cell line
16HBE14o-. Furthermore, they demonstrate that a possi-
ble mechanism is the induction of apoptosis via the mito-
chondrial pathway, a phenomenon also shown in
primary cells from asthmatic subjects [32].
It has been shown that differentiated bronchial epithelial
cells grown in air-liquid interface and developing tight
junctions, are considerably resistant to RV infection [20].
In this respect, the results of this study, using submerged
cultures that lead to non-differentiated cells, may overes-
Cytotoxicity of active and heat inactivated RV1b (MOI = 1)  on 50% confluent BEAS-2B cells Figure 3
Cytotoxicity of active and heat inactivated RV1b (MOI = 1) 
on 50% confluent BEAS-2B cells. Inactivated virus is no 
longer cytotoxic (*p = 0.021, n = 4, Mann Whitney).
RV 1b RV1b+Heat
0
25
50
75
C
y
t
o
t
o
x
i
c
i
t
y
(
%
o
v
e
r
c
o
n
t
r
o
l
)
*Respiratory Research 2005, 6:114 http://respiratory-research.com/content/6/1/114
Page 7 of 11
(page number not for citation purposes)
timate the in-vivo situation. However, a characteristic of
asthma is the significant loss of columnar epithelial cells
leading to loss of its integrity and density [4], epithelial
damage also correlates to the severity of the disease [33]
In this respect, sparsely seeded bronchial epithelial cell
cultures, can be considered as an extreme, but relevant
model of asthmatic epithelium. Under such conditions, as
show herein, RV-associated cytotoxicity increases consid-
erably, with almost linear density-dependence, suggesting
that virus-induced exacerbations may have increased
sequels in more severe patients [34].
The fact that different RV serotypes are not equally capable
of killing epithelial cells, ranging from no to extensive
cytotoxicity, supports the possibility that this phenome-
non may contribute to asthma exacerbation severity vari-
ations observed in clinical practice [35].
RV infects a small proportion of exposed cells [15]; biopsy
data show that in human RV infection epithelial inflam-
mation, potentially resulting from infection, is patchy
[27,36]: there has been, however, no direct comparison
between normal and asthmatic individuals in regard to
RV-induced cytotoxicity in-vivo, a study complicated by
the fact that the epithelial integrity and viability is consid-
erably affected in asthmatics at baseline. In a recent study,
Wark et al showed increased RV proliferation in primary
epithelial cells obtained from asthmatic patients in com-
parison to normal controls [32]. We have also observed
that exposure of BEAS-2B cells to culture supernatants
Damaged epithelium (t = 0) is suboptimally repopulated after RV-infection in comparison to control BEAS-2B cells Figure 4
Damaged epithelium (t = 0) is suboptimally repopulated after RV-infection in comparison to control BEAS-2B cells. DAPI 
stained cells (A). Repopulation of damaged epithelium, expressed as unpopulated area in mm2, in RV-infected and non-infected 
BEAS-2B cells, immediately after damage (t = 0) and at 24, 48 and 72 hours later (B). Repopulation in infected cells is signifi-
cantly reduced (*p < 0.05, **p = 0.001, n = 8, Mann Whitney).
→ → → →←
Baseline 24h-Control
→ → → →← → → → →←
24h-RV infected
Control
RV1b
**
*
*
02 44 8 7 2
Time (hours)
0
50
100
150
D
a
m
a
g
e
d
u
n
p
o
p
u
l
a
t
e
d
a
r
e
a
(
S
q
u
a
r
e
m
m
)
B
ARespiratory Research 2005, 6:114 http://respiratory-research.com/content/6/1/114
Page 8 of 11
(page number not for citation purposes)
Proliferation of BEAS-2B cells, as mean fluorescence intensity (MFI) of PCNA in RV-infected and control cells at various time  points after reculture (A) Figure 5
Proliferation of BEAS-2B cells, as mean fluorescence intensity (MFI) of PCNA in RV-infected and control cells at various time 
points after reculture (A). The proliferation rate is significantly reduced for RV-infected cells at all time points (*p = 0.012, ** p 
< 0.05, n = 3–7, Mann Whitney). Representative histograms at t = 0 and 24 hours are shown (B). Closed line: isotype control, 
thick line: RV-infected, dashed line: non-infected control cells.
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modeling an 'atopic' environment, was also able to
increase RV proliferation, and at the same time increase
RV-induced cytotoxicity [37]. These observations further
suggest that RV-induced cytotoxicity may be relevant in
asthma exacerbation pathogenesis.
There are several possibilities in respect to the mecha-
nism(s) underlying this phenomenon, which have not,
however, been addressed in this study. One possibility
might be that rapidly dividing cells, as is the case of sparse
cultures, may be more permissive to RV infection. Moreo-
ver, differential expression of soluble factors, such as
interferons, may regulate either susceptibility to infection
or the proliferative potential of RV. These hypotheses,
which may well not be mutually exclusive and could all
contribute to RV cytotoxicity, are currently under investi-
gation.
Independent of the causative mechanism(s), in an already
affected epithelium, RV infection may lead to more pro-
found damage. This would eventually lead to activation of
repair mechanisms: deposition of extracellular matrix,
proliferation and migration of epithelial cells in order to
repopulate the damaged area, followed by cell differentia-
tion [1,2]. Hence, we used a previously validated wound
model [38,39] to investigate the role of RV infection on
the repair process, describing for the first time an RV-
mediated delay in epithelial wound healing, associated
with reduced proliferation of RV infected cells. This find-
ing may be of significance as altered restitution of airway
structure is one of hallmarks of asthmatic inflammation
leading to airway remodeling [4]. Damaged asthmatic epi-
thelium has been previously reported to have prolifera-
tion defects during the repair process [40]. Dysregulated
proliferation in bronchial epithelial cells from asthmatic
patients has been associated with increased expression of
the cyclin-dependent kinase inhibitor p21waf [41,42]. In
severe, corticosteroid-dependent asthma, markers of epi-
thelial cell proliferation are coexpressed with markers of
activation, suggesting that, in at least that case, the repair
process is associated with a persistent activation state of
the epithelial cells [41]. The above findings have led inves-
tigators to propose that a repair/activation imbalance may
be the central mechanism of airway remodeling in asthma
[5]. In this respect, RV-induced cytotoxicity, an event fre-
quently occurring and able to activate epithelial cells into
an inflammatory response [16], may be implicated in the
development of remodeling. The possibility that a viral
infection may reprogram epithelial responses towards a
'remodeled' phenotype has also been proposed, based on
a mouse model of paramyxoviral infection [43].
Conclusion
In conclusion, several human RV serotypes are able to
become cytotoxic to human bronchial epithelial cells,
especially when these are sparsely cultured; RVs are also
able to delay epithelial wound healing. Previously unrec-
ognised, RV-induced cytotoxicity may become important
in the context of asthma in which the epithelium is
already affected and consequently contribute to the induc-
tion and/or perpetuation of airway remodelling.
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